Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Dermal Fillers Market Research Report Information by Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid, and Others) by Application (Facial Line Correction, Face lift, Lip Enhancement, and Others), by End User (Specialty & Dermatology Clinics, Hospitals, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032


ID: MRFR/Pharma/2606-CR | 110 Pages | Author: Rahul Gotadki| February 2024

Dermal Fillers Market Segmentation


Dermal Fillers Type Outlook (USD Billion, 2019-2032)



  • Hyaluronic Acid

  • Calcium Hydroxylapatite

  • Poly-L-Lactic Acid

  • Others


Dermal Fillers Application Outlook (USD Billion, 2019-2032)



  • Facial Line Correction

  • Face lift

  • Lip Enhancement

  • Others


Dermal Fillers End User Outlook (USD Billion, 2019-2032)



  • Specialty & Dermatology Clinics

  • Hospitals

  • Others


Dermal Fillers Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)


    • North America Dermal Fillers by Type

      • Hyaluronic Acid

      • Calcium Hydroxylapatite

      • Poly-L-Lactic Acid

      • Others




    • North America Dermal Fillers by Application

      • Facial Line Correction

      • Face lift

      • Lip Enhancement

      • Others




    • North America Dermal Fillers by End User

      • Specialty & Dermatology Clinics

      • Hospitals

      • Others



    • US Outlook (USD Billion, 2019-2032)


    • US Dermal Fillers by Type

      • Hyaluronic Acid

      • Calcium Hydroxylapatite

      • Poly-L-Lactic Acid

      • Others




    • US Dermal Fillers by Application

      • Facial Line Correction

      • Face lift

      • Lip Enhancement

      • Others




    • US Dermal Fillers by End User

      • Specialty & Dermatology Clinics

      • Hospitals

      • Others



    • Canada Outlook (USD Billion, 2019-2032)


    • Canada Dermal Fillers by Type

      • Hyaluronic Acid

      • Calcium Hydroxylapatite

      • Poly-L-Lactic Acid

      • Others




    • Canada Dermal Fillers by Application

      • Facial Line Correction

      • Face lift

      • Lip Enhancement

      • Others




    • Canada Dermal Fillers by End User

      • Specialty & Dermatology Clinics

      • Hospitals

      • Others




    • Europe Outlook (USD Billion, 2019-2032)


      • Europe Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • Europe Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • Europe Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others




      • Germany Outlook (USD Billion, 2019-2032)


      • Germany Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • Germany Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • Germany Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others



      • France Outlook (USD Billion, 2019-2032)


      • France Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • France Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • France Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others



      • UK Outlook (USD Billion, 2019-2032)


      • UK Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • UK Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • UK Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others



      • Italy Outlook (USD Billion, 2019-2032)


      • Italy Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • Italy Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • Italy Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others



      • Spain Outlook (USD Billion, 2019-2032)


      • Spain Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • Spain Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • Spain Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others



      • Rest Of Europe Outlook (USD Billion, 2019-2032)


      • Rest of Europe Dermal Fillers by Type

        • Hyaluronic Acid

        • Calcium Hydroxylapatite

        • Poly-L-Lactic Acid

        • Others




      • Rest of Europe Dermal Fillers by Application

        • Facial Line Correction

        • Face lift

        • Lip Enhancement

        • Others




      • Rest of Europe Dermal Fillers by End User

        • Specialty & Dermatology Clinics

        • Hospitals

        • Others




      • Asia-Pacific Outlook (USD Billion, 2019-2032)


        • Asia-Pacific Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • Asia-Pacific Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • Asia-Pacific Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • China Outlook (USD Billion, 2019-2032)


        • China Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • China Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • China Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • Japan Outlook (USD Billion, 2019-2032)


        • Japan Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • Japan Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • Japan Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • India Outlook (USD Billion, 2019-2032)


        • India Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • India Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • India Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • Australia Outlook (USD Billion, 2019-2032)


        • Australia Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • Australia Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • Australia Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • South Korea Outlook (USD Billion, 2019-2032)


        • South Korea Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • South Korea Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • South Korea Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)


        • Rest of Asia-Pacific Dermal Fillers by Type

          • Hyaluronic Acid

          • Calcium Hydroxylapatite

          • Poly-L-Lactic Acid

          • Others




        • Rest of Asia-Pacific Dermal Fillers by Application

          • Facial Line Correction

          • Face lift

          • Lip Enhancement

          • Others




        • Rest of Asia-Pacific Dermal Fillers by End User

          • Specialty & Dermatology Clinics

          • Hospitals

          • Others




        • Rest of the World Outlook (USD Billion, 2019-2032)


          • Rest of the World Dermal Fillers by Type

            • Hyaluronic Acid

            • Calcium Hydroxylapatite

            • Poly-L-Lactic Acid

            • Others




          • Rest of the World Dermal Fillers by Application

            • Facial Line Correction

            • Face lift

            • Lip Enhancement

            • Others




          • Rest of the World Dermal Fillers by End User

            • Specialty & Dermatology Clinics

            • Hospitals

            • Others




          • Middle East Outlook (USD Billion, 2019-2032)


          • Middle East Dermal Fillers by Type

            • Hyaluronic Acid

            • Calcium Hydroxylapatite

            • Poly-L-Lactic Acid

            • Others




          • Middle East Dermal Fillers by Application

            • Facial Line Correction

            • Face lift

            • Lip Enhancement

            • Others




          • Middle East Dermal Fillers by End User

            • Specialty & Dermatology Clinics

            • Hospitals

            • Others




          • Africa Outlook (USD Billion, 2019-2032)


          • Africa Dermal Fillers by Type

            • Hyaluronic Acid

            • Calcium Hydroxylapatite

            • Poly-L-Lactic Acid

            • Others




          • Africa Dermal Fillers by Application

            • Facial Line Correction

            • Face lift

            • Lip Enhancement

            • Others




          • Africa Dermal Fillers by End User

            • Specialty & Dermatology Clinics

            • Hospitals

            • Others




          • Latin America Outlook (USD Billion, 2019-2032)


          • Latin America Dermal Fillers by Type

            • Hyaluronic Acid

            • Calcium Hydroxylapatite

            • Poly-L-Lactic Acid

            • Others




          • Latin America Dermal Fillers by Application

            • Facial Line Correction

            • Face lift

            • Lip Enhancement

            • Others




          • Latin America Dermal Fillers by End User

            • Specialty & Dermatology Clinics

            • Hospitals

            • Others











Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 13

1.1 OVERVIEW 13

1.1.1 MARKET SYPNOSIS 13

2 MARKET INTRODUCTION 15

2.1 DEFINITION 15

2.2 SCOPE OF THE STUDY 15

2.3 RESEARCH OBJECTIVE 15

2.4 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY 17

3.1 OVERVIEW 17

3.2 DATA MINING 17

3.3 SECONDARY RESEARCH 18

3.4 PRIMARY RESEARCH 19

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 23

3.7 DATA TRIANGULATION 24

3.8 VALIDATION 24

4 MARKET DYNAMICS 25

4.1 OVERVIEW 25

4.2 DRIVERS 26

4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS GLOBALLY 26

4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 26

4.2.3 COST-EFFECTIVE ALTERNATIVE TO COSMETIC SURGERIES 26

4.3 RESTRAINTS 27

4.3.1 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 27

4.3.2 BLACK MARKET OF DERMAL FILLERS AND EFFECTS OF UNREGISTERED PRACTITIONERS 28

4.4 OPPORTUNITIES 29

4.4.1 INCREASING NUMBER OF CLINICAL TRIAL STUDIES 29

4.4.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 29

5 MARKET FACTOR ANALYSIS 30

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D 31

5.1.2 MANUFACTURING 31

5.1.3 MARKETING AND DISTRIBUTION 31

5.1.4 POST-SALES MONITORING 31

5.2 PORTER'S FIVE FORCES MODEL 32

5.2.1 THREAT OF NEW ENTRANTS 32

5.2.2 BARGAINING POWER OF SUPPLIERS 33

5.2.3 THREAT OF SUBSTITUTES 33

5.2.4 BARGAINING POWER OF BUYERS 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 IMPACT OF COVID-19 ON THE GLOBAL DERMAL FILLERS MARKET 34

5.3.1 IMPACT ON SUPPLY CHAIN 34

5.3.2 IMPACT ON DEMAND AND SUPPLY 34

5.3.3 IMPACT ON REGIONS 34

6 GLOBAL DERMAL FILLERS MARKET, BY TYPE 35

6.1 OVERVIEW 35

6.2 HYALURONIC ACID 38

6.3 CALCIUM HYDROXYLAPATITE 39

6.4 POLY-L-LACTIC ACID 39

6.5 OTHERS 40

7 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION 41

7.1 OVERVIEW 41

7.2 FACIAL LINE CORRECTION 43

7.3 FACE LIFT 44

7.4 LIP ENHANCEMENT 44

7.5 OTHERS 45

8 GLOBAL DERMAL FILLERS MARKET, BY END USER 46

8.1 OVERVIEW 46

8.2 SPECIALTY & DERMATOLOGY CLINICS 48

8.3 HOSPITALS 49

8.4 OTHERS 49

9 GLOBAL DERMAL FILLERS MARKET, BY REGION 50

9.1 OVERVIEW 50

9.2 NORTH AMERICA 53

9.2.1 US 56

9.2.2 CANADA 57

9.3 EUROPE 58

9.3.1 GERMANY 61

9.3.2 UK 62

9.3.3 FRANCE 63

9.3.4 ITALY 64

9.3.5 SPAIN 65

9.3.6 REST OF EUROPE 66

9.4 ASIA-PACIFIC 67

9.4.1 CHINA 70

9.4.2 INDIA 71

9.4.3 JAPAN 72

9.4.4 AUSTRALIA 73

9.4.5 SOUTH KOREA 74

9.4.6 REST OF ASIA-PACIFIC 75

9.5 REST OF THE WORLD 76

9.5.1 MIDDLE EAST 79

9.5.2 AFRICA 80

9.5.3 LATIN AMERICA 81

10 COMPETITIVE LANDSCAPE 82

10.1 OVERVIEW 82

10.2 COMPETITIVE BENCHMARKING 83

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL DERMAL FILLERS MARKET 84

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL DERMAL FILLERS MARKET 84

10.5 KEY DEVELOPMENT ANALYSIS 85

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 85

10.6.1 ACQUISITION 85

10.6.2 PRODUCT APPROVAL AND LAUNCH 85

10.6.3 EXPANSION 87

10.6.4 PARTNERSHIP/AGREEMENT 87

11 COMPANY PROFILES 88

11.1 ABBVIE INC. 88

11.1.1 COMPANY OVERVIEW 88

11.1.2 FINANCIAL OVERVIEW 89

11.1.3 PRODUCTS OFFERED 89

11.1.4 ABBVIE INC.: KEY DEVELOPMENTS 90

11.1.5 SWOT ANALYSIS 91

11.1.6 KEY STRATEGIES 91

11.2 DR. KORMAN LABORATORIES 92

11.2.1 COMPANY OVERVIEW 92

11.2.2 FINANCIAL OVERVIEW 92

11.2.3 PRODUCTS OFFERED 92

11.2.4 KEY DEVELOPMENTS 92

11.2.5 SWOT ANALYSIS 93

11.2.6 KEY STRATEGIES 93

11.3 TEOXANE LABORATORIES 94

11.3.1 COMPANY OVERVIEW 94

11.3.2 FINANCIAL OVERVIEW 94

11.3.3 PRODUCTS OFFERED 94

11.3.4 KEY DEVELOPMENTS 95

11.3.5 SWOT ANALYSIS 95

11.3.6 KEY STRATEGIES 95

11.4 SCIVISION BIOTECH INC. 96

11.4.1 COMPANY OVERVIEW 96

11.4.2 FINANCIAL OVERVIEW 96

11.4.3 PRODUCTS OFFERED 96

11.4.4 KEY DEVELOPMENTS 96

11.4.5 KEY STRATEGIES 96

11.5 BRIDGEPOINT GROUP PLC 97

11.5.1 COMPANY OVERVIEW 97

11.5.2 FINANCIAL OVERVIEW 97

11.5.3 PRODUCTS OFFERED 97

11.5.4 KEY DEVELOPMENTS 97

11.5.5 KEY STRATEGIES 97

11.6 GALDERMA LABORATORIES, L.P 98

11.6.1 COMPANY OVERVIEW 98

11.6.2 FINANCIAL OVERVIEW 98

11.6.3 PRODUCTS OFFERED 98

11.6.4 KEY DEVELOPMENTS 99

11.6.5 SWOT ANALYSIS 100

11.6.6 KEY STRATEGIES 100

11.7 MERZ PHARMA 101

11.7.1 COMPANY OVERVIEW 101

11.7.2 FINANCIAL OVERVIEW 101

11.7.3 PRODUCTS OFFERED 101

11.7.4 KEY DEVELOPMENTS 102

11.7.5 SWOT ANALYSIS 102

11.7.6 KEY STRATEGIES 102

11.8 SINCLAIR PHARMA 103

11.8.1 COMPANY OVERVIEW 103

11.8.2 FINANCIAL OVERVIEW 104

11.8.3 PRODUCTS OFFERED 105

11.8.4 KEY DEVELOPMENTS 105

11.8.5 KEY STRATEGIES 105

11.9 SUNEVA MEDICAL 106

11.9.1 COMPANY OVERVIEW 106

11.9.2 FINANCIAL OVERVIEW 106

11.9.3 PRODUCTS OFFERED 106

11.9.4 KEY DEVELOPMENTS 106

11.9.5 KEY STRATEGIES 106

11.10 MEDYTOX 107

11.10.1 COMPANY OVERVIEW 107

11.10.2 FINANCIAL OVERVIEW 107

11.10.3 PRODUCTS OFFERED 107

11.10.4 KEY DEVELOPMENTS 107

11.10.5 KEY STRATEGIES 108

12 APPENDIX 109

12.1 REFERENCES 109

12.2 RELATED REPORTS 110

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 36

TABLE 3 GLOBAL DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY REGION, 2019–2032 (USD BILLION) 38

TABLE 4 GLOBAL DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY REGION, 2019–2032 (USD BILLION) 39

TABLE 5 GLOBAL DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY REGION, 2019–2032 (USD BILLION) 39

TABLE 6 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION) 40

TABLE 7 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 42

TABLE 8 GLOBAL DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION, BY REGION, 2019–2032 (USD BILLION) 43

TABLE 9 GLOBAL DERMAL FILLERS MARKET, FOR FACE LIFT, BY REGION, 2019–2032 (USD BILLION) 44

TABLE 10 GLOBAL DERML FILLERS MARKET, FOR LIP ENHANCEMENT, BY REGION, 2019–2032 (USD BILLION) 44

TABLE 11 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY ERGION, 2019–2032 (USD BILLION) 45

TABLE 12 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 47

TABLE 13 GLOBAL DERMAL FILLERS MARKET, FOR SPECIALTY & DERMATOLOGY CLINICS, BY REGION, 2019–2032 (USD BILLION) 48

TABLE 14 GLOBAL DERMAL FILLERS MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD BILLION) 49

TABLE 15 GLOBAL DERMAL FILLERS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION) 49

TABLE 16 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2019–2032 (USD BILLION) 51

TABLE 17 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 52

TABLE 18 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 52

TABLE 19 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 52

TABLE 20 NORTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD BILLION) 54

TABLE 21 NORTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 54

TABLE 22 NORTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 55

TABLE 23 NORTH AMERICA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 55

TABLE 24 US: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 56

TABLE 25 US: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 56

TABLE 26 US: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 56

TABLE 27 CANADA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 57

TABLE 28 CANADA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 57

TABLE 29 CANADA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 57

TABLE 30 EUROPE: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD BILLION) 59

TABLE 31 EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 60

TABLE 32 EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 60

TABLE 33 EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 60

TABLE 34 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 61

TABLE 35 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 61

TABLE 36 GERMANY: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 61

TABLE 37 UK: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 62

TABLE 38 UK: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 62

TABLE 39 UK: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 62

TABLE 40 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 63

TABLE 41 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 63

TABLE 42 FRANCE: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 63

TABLE 43 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 64

TABLE 44 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 64

TABLE 45 ITALY: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 64

TABLE 46 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 65

TABLE 47 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 65

TABLE 48 SPAIN: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 65

TABLE 49 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 66

TABLE 50 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 66

TABLE 51 REST OF EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 66

TABLE 52 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD BILLION) 68

TABLE 53 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 69

TABLE 54 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 69

TABLE 55 ASIA-PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 69

TABLE 56 CHINA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 70

TABLE 57 CHINA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 70

TABLE 58 CHINA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 70

TABLE 59 INDIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 71

TABLE 60 INDIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 71

TABLE 61 INDIA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 71

TABLE 62 JAPAN: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 72

TABLE 63 JAPAN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 72

TABLE 64 JAPAN: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 72

TABLE 65 AUSTRALIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 73

TABLE 66 AUSTRALIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 73

TABLE 67 AUSTRALIA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 73

TABLE 68 SOUTH KOREA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 74

TABLE 69 SOUTH KOREA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 74

TABLE 70 SOUTH KOREA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 74

TABLE 71 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 75

TABLE 72 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 75

TABLE 73 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 75

TABLE 74 REST OF THE WORLD: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD BILLION) 77

TABLE 75 REST OF THE WORLD: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 78

TABLE 76 REST OF THE WORLD: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 78

TABLE 77 REST OF THE WORLD: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 78

TABLE 78 MIDDLE EAST: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 79

TABLE 79 MIDDLE EAST: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 79

TABLE 80 MIDDLE EAST: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 79

TABLE 81 AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 80

TABLE 82 AFRICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 80

TABLE 83 AFRICA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 80

TABLE 84 LATIN AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD BILLION) 81

TABLE 85 LATIN AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD BILLION) 81

TABLE 86 LATIN AMERICA: DERMAL FILLERS MARKET, BY END USER, 2019–2032 (USD BILLION) 81

TABLE 87 MAJOR PLAYERS IN THE GLOBAL DERMAL FILLERS MARKET 82

TABLE 88 MOST ACTIVE PLAYER IN THE GLOBAL DERMAL FILLERS MARKET 84

TABLE 89 ACQUISITION: GLOBAL DERMAL FILLERS MARKET 85

TABLE 90 PRODUCT APPROVAL AND LAUNCH: GLOBAL DERMAL FILLERS MARKET 85

TABLE 91 EXPANSION: GLOBAL DERMAL FILLERS MARKET 87

TABLE 92 PARTNERSHIP/AGREEMENT: GLOBAL DERMAL FILLERS MARKET 87

TABLE 93 ABBVIE INC.: PRODUCTS OFFERED 89

TABLE 94 ABBVIE INC.: KEY DEVELOPMENTS 90

TABLE 95 DR. KORMAN LABORATORIES: PRODUCTS OFFERED 92

TABLE 96 TEOXANE LABORATORIES: PRODUCTS OFFERED 94

TABLE 97 TEOXANE LABORATORIES: KEY DEVELOPMENTS 95

TABLE 98 SCIVISION BIOTECH INC.: PRODUCTS OFFERED 96

TABLE 99 BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED 97

TABLE 100 GALDERMA LABORATORIES, L.P: PRODUCTS OFFERED 98

TABLE 101 GALDERMA LABORATORIES, L.P: KEY DEVELOPMENTS 99

TABLE 102 MERZ PHARMA: PRODUCTS OFFERED 101

TABLE 103 MERZ PHARMA: KEY DEVELOPMENTS 102

TABLE 104 SINCLAIR PHARMA: PRODUCTS OFFERED 105

TABLE 105 SINCLAIR PHARMA: KEY DEVELOPMENTS 105

TABLE 106 SUNEVA MEDICAL: PRODUCTS OFFERED 106

TABLE 107 SUNEVA MEDICAL: KEY DEVELOPMENTS 106

TABLE 108 MEDYTOX: PRODUCTS OFFERED 107

LIST OF FIGURES

FIGURE 1 GLOBAL DERMAL FILLERS MARKET STRUCTURE 16

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL DERMAL FILLERS MARKET 25

FIGURE 4 DRIVERS IMPACT ANALYSIS 27

FIGURE 5 RESTRAINTS IMPACT ANALYSIS 28

FIGURE 6 VALUE CHAIN: GLOBAL DERMAL FILLERS MARKET 30

FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DERMAL FILLERS MARKET 32

FIGURE 8 GLOBAL DERMAL FILLERS MARKET, TYPE SEGMENT ATTRACTIVENESS, (USD BILLION) 35

FIGURE 9 GLOBAL DERMAL FILLERS MARKET, BY TYPE, 2022 & 2032 (USD BILLION) 36

FIGURE 10 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY TYPE, 2022 38

FIGURE 11 GLOBAL DERMAL FILLERS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD BILLION) 41

FIGURE 12 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION) 42

FIGURE 13 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY APPLICATION, 2022 43

FIGURE 14 GLOBAL DERMAL FILLERS MARKET, END USER SEGMENT ATTRACTIVENESS, (USD BILLION) 46

FIGURE 15 GLOBAL DERMAL FILLERS MARKET, BY END USER, 2022 & 2032 (USD BILLION) 47

FIGURE 16 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY END USER, 2022 48

FIGURE 17 GLOBAL DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022 50

FIGURE 18 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2022 & 2032 (USD BILLION) 51

FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019–2032 (USD BILLION) 53

FIGURE 20 NORTH AMERICA: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022 54

FIGURE 21 EUROPE MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019–2032 (USD BILLION) 58

FIGURE 22 EUROPE: DERMAL FILLERS MARKET SHARE (%), BY COUNTRY, 2022 59

FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019–2032 (USD BILLION) 67

FIGURE 24 ASIA-PACIFIC: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022 68

FIGURE 25 REST OF THE WORLD MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019–2032 (USD BILLION) 76

FIGURE 26 REST OF THE WORLD: DERMAL FILLERS MARKET SHARE (%), BY REGION, 2022 77

FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 83

FIGURE 28 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL DERMAL FILLERS MARKET 84

FIGURE 29 GLOBAL DERMAL FILLERS MARKET: COMPETITIVE LANDSCAPE 85

FIGURE 30 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT 89

FIGURE 31 ABBVIE INC.: SWOT ANALYSIS 91

FIGURE 32 DR. KORMAN LABORATORIES: SWOT ANALYSIS 93

FIGURE 33 TEOXANE LABORATORIES: SWOT ANALYSIS 95

FIGURE 34 GALDERMA LABORATORIES, L.P.: SWOT ANALYSIS 100

FIGURE 35 MERZ PHARMA: SWOT ANALYSIS 102

FIGURE 36 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT 104

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.